Market Segmentation
- Ankylosing Spondylitis Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Ankylosing Spondylitis Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Ankylosing Spondylitis Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- North America Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- North America Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- U.S.
- U.S. Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- U.S. Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- U.S. Ankylosing Spondylitis Market, by Drug Class
- Canada
- Canada Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Canada Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Canada Ankylosing Spondylitis Market, by Drug Class
- Mexico
- Mexico Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Mexico Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Mexico Ankylosing Spondylitis Market, by Drug Class
- North America Ankylosing Spondylitis Market, by Drug Class
- Europe
- Europe Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Europe Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- UK
- UK Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- UK Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- UK Ankylosing Spondylitis Market, by Drug Class
- Germany
- Germany Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Germany Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Germany Ankylosing Spondylitis Market, by Drug Class
- France
- France Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- France Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- France Ankylosing Spondylitis Market, by Drug Class
- Italy
- Italy Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Italy Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Italy Ankylosing Spondylitis Market, by Drug Class
- Spain
- Spain Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Spain Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Spain Ankylosing Spondylitis Market, by Drug Class
- Denmark
- Denmark Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Denmark Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Denmark Ankylosing Spondylitis Market, by Drug Class
- Sweden
- Sweden Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Sweden Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Sweden Ankylosing Spondylitis Market, by Drug Class
- Norway
- Norway Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Norway Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Norway Ankylosing Spondylitis Market, by Drug Class
- Europe Ankylosing Spondylitis Market, by Drug Class
- Asia Pacific
- Asia Pacific Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Asia Pacific Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Japan
- Japan Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Japan Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Japan Ankylosing Spondylitis Market, by Drug Class
- China
- China Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- China Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- China Ankylosing Spondylitis Market, by Drug Class
- India
- India Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- India Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- India Ankylosing Spondylitis Market, by Drug Class
- Australia
- Australia Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Australia Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Australia Ankylosing Spondylitis Market, by Drug Class
- South Korea
- South Korea Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- South Korea Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- South Korea Ankylosing Spondylitis Market, by Drug Class
- Thailand
- Thailand Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Thailand Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Thailand Ankylosing Spondylitis Market, by Drug Class
- Asia Pacific Ankylosing Spondylitis Market, by Drug Class
- Latin America
- Latin America Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Latin America Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Brazil
- Brazil Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Brazil Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Brazil Ankylosing Spondylitis Market, by Drug Class
- Argentina
- Argentina Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Argentina Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Argentina Ankylosing Spondylitis Market, by Drug Class
- Latin America Ankylosing Spondylitis Market, by Drug Class
- Middle East & Africa
- Middle East & Africa Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Middle East & Africa Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- South Africa
- South Africa Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- South Africa Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- South Africa Ankylosing Spondylitis Market, by Drug Class
- Saudi Arabia
- Saudi Arabia Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Saudi Arabia Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Saudi Arabia Ankylosing Spondylitis Market, by Drug Class
- UAE
- UAE Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- UAE Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- UAE Ankylosing Spondylitis Market, by Drug Class
- Kuwait
- Kuwait Ankylosing Spondylitis Market, by Drug Class
- Non-Steroidal Anti-Inflammatory Drug (NSAID)
- TNF Inhibitors
- Humira
- Simponi
- Remicade
- Enbrel
- Cimzia
- Other TNF Inhibitors
- Other Drug Classes
- Kuwait Ankylosing Spondylitis Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Kuwait Ankylosing Spondylitis Market, by Drug Class
- Middle East & Africa Ankylosing Spondylitis Market, by Drug Class
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2021 to 2033
- Market estimates and forecast for product segments up to 2033
- Regional market size and forecast for product segments up to 2033
- Market estimates and forecast for application segments up to 2033
- Regional market size and forecast for application segments up to 2033
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
